title: Feasibility, safety and dosimetry of intramural administration of 32P-oligonucleotide-mediating beta-particle delivery to prevent restenosis.
authors.affiliation: Angiogene Inc., Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
authors.initials: J
authors.lastname: Fareh
authors.initials: R
authors.lastname: Martel
authors.initials: G
authors.lastname: Leclerc